Clifford Swan Investment Counsel LLC Novo Nordisk A S Transaction History

Clifford Swan Investment Counsel LLC

  • $2.68 Billion
  • Q1 2024

A detailed history of Clifford Swan Investment Counsel LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 199,370 shares of NVO stock, worth $28.4 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
199,370
Previous 210,276 5.19%
Holding current value
$28.4 Million
Previous $21.8 Million 17.68%
% of portfolio
0.96%
Previous 0.85%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024
SELL
$102.11 - $135.92 $1.11 Million - $1.48 Million
-10,906 Reduced 5.19%
199,370 $25.6 Million
Q4 2023

Feb 06, 2024
SELL
$87.78 - $105.45 $157,213 - $188,860
-1,791 Reduced 0.84%
210,276 $21.8 Million
Q3 2023

Nov 09, 2023
BUY
$90.94 - $199.54 $9.57 Million - $21 Million
105,192 Added 98.43%
212,067 $19.3 Million
Q2 2023

Aug 03, 2023
SELL
$155.98 - $172.65 $248,788 - $275,376
-1,595 Reduced 1.47%
106,875 $17.3 Million
Q1 2023

May 05, 2023
SELL
$132.34 - $159.14 $275,399 - $331,170
-2,081 Reduced 1.88%
108,470 $17.3 Million
Q4 2022

Feb 02, 2023
SELL
$102.55 - $135.33 $167,669 - $221,264
-1,635 Reduced 1.46%
110,551 $15 Million
Q3 2022

Nov 04, 2022
SELL
$95.28 - $116.93 $172,933 - $212,227
-1,815 Reduced 1.59%
112,186 $11.2 Million
Q2 2022

Aug 04, 2022
SELL
$103.24 - $121.81 $23,745 - $28,016
-230 Reduced 0.2%
114,001 $12.7 Million
Q1 2022

May 03, 2022
SELL
$93.1 - $112.54 $41,243 - $49,855
-443 Reduced 0.39%
114,231 $12.7 Million
Q4 2021

Feb 11, 2022
SELL
$95.88 - $117.08 $121,767 - $148,691
-1,270 Reduced 1.1%
114,674 $12.8 Million
Q3 2021

Nov 02, 2021
BUY
$84.42 - $106.62 $70,490 - $89,027
835 Added 0.73%
115,944 $11.1 Million
Q2 2021

Aug 05, 2021
SELL
$67.66 - $84.76 $103,519 - $129,682
-1,530 Reduced 1.31%
115,109 $11.3 Million
Q1 2021

May 07, 2021
SELL
$67.06 - $75.82 $109,710 - $124,041
-1,636 Reduced 1.38%
116,639 $7.86 Million
Q4 2020

Feb 11, 2021
SELL
$63.89 - $73.8 $176,591 - $203,983
-2,764 Reduced 2.28%
118,275 $8.26 Million
Q3 2020

Oct 30, 2020
SELL
$63.69 - $70.22 $236,162 - $260,375
-3,708 Reduced 2.97%
121,039 $8.4 Million
Q2 2020

Aug 06, 2020
SELL
$58.54 - $67.94 $151,208 - $175,489
-2,583 Reduced 2.03%
124,747 $8.17 Million
Q1 2020

Apr 09, 2020
SELL
$49.46 - $64.78 $159,508 - $208,915
-3,225 Reduced 2.47%
127,330 $7.67 Million
Q4 2019

Jan 30, 2020
SELL
$49.86 - $58.26 $488,278 - $570,540
-9,793 Reduced 6.98%
130,555 $7.56 Million
Q3 2019

Nov 12, 2019
SELL
$47.54 - $53.43 $213,359 - $239,793
-4,488 Reduced 3.1%
140,348 $7.26 Million
Q2 2019

Aug 13, 2019
SELL
$46.79 - $52.47 $847,600 - $950,494
-18,115 Reduced 11.12%
144,836 $7.39 Million
Q1 2019

May 14, 2019
SELL
$46.36 - $52.63 $520,854 - $591,298
-11,235 Reduced 6.45%
162,951 $8.52 Million
Q4 2018

Feb 13, 2019
SELL
$41.54 - $47.25 $336,889 - $383,197
-8,110 Reduced 4.45%
174,186 $8.03 Million
Q3 2018

Nov 14, 2018
SELL
$46.76 - $51.24 $859,308 - $941,637
-18,377 Reduced 9.16%
182,296 $8.59 Million
Q2 2018

Aug 13, 2018
SELL
$44.29 - $50.42 $1.17 Million - $1.33 Million
-26,469 Reduced 11.65%
200,673 $9.26 Million
Q1 2018

May 09, 2018
SELL
$48.49 - $58.14 $2.54 Million - $3.05 Million
-52,478 Reduced 18.77%
227,142 $11.2 Million
Q4 2017

Feb 09, 2018
BUY
$47.53 - $53.73 $446,116 - $504,309
9,386 Added 3.47%
279,620 $15 Million
Q3 2017

Nov 13, 2017
SELL
$41.15 - $49.22 $238,464 - $285,229
-5,795 Reduced 2.1%
270,234 $13 Million
Q2 2017

Aug 11, 2017
BUY
N/A
276,029
276,029 $11.8 Million

Others Institutions Holding NVO

# of Institutions
1,861
Shares Held
310M
Call Options Held
5.29M
Put Options Held
4.93M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email